Journal of Vaccine Research 2024, Vol.14, No.3, 120-134 http://medscipublisher.com/index.php/jvr 129 8 Challenges and Limitations 8.1 Technical challenges in genetic modification and transplantation Genetic modification of pigs for xenotransplantation involves intricate technical processes that pose significant challenges. One primary technical challenge is achieving precise and stable integration of human genes into the pig genome. Techniques like CRISPR/Cas9, although highly effective, can still result in unintended genomic modifications. For example, the insertion of human genes to prevent hyperacute rejection or enhance compatibility must be accurately targeted to avoid disrupting essential pig genes or causing off-target effects. A study on ex vivo gene editing of kidneys highlighted the difficulty in silencing major histocompatibility complex (MHC) antigens without triggering adverse immune responses during organ perfusion (Yuzefovych et al., 2020). Another challenge is ensuring the viability and function of the genetically modified organs. Genetic modifications often involve multiple gene edits, each carrying the risk of unintended consequences that could impair organ function. The production of transgenic pigs with multiple modifications requires sophisticated breeding and screening processes to ensure the desired traits are reliably expressed without compromising overall health and viability (Mohiuddin et al., 2016). Additionally, the transplantation process itself poses technical hurdles. The surgical techniques for xenotransplantation are complex and require meticulous planning and execution. Ensuring proper vascular anastomosis and minimizing ischemia-reperfusion injury are critical for the success of the transplant. Innovations in surgical techniques and pre-transplant conditioning protocols are necessary to enhance graft survival and function (Soltys et al., 2017). 8.2 Potential off-target effects and genetic stability One of the significant concerns with genetic modification is the potential for off-target effects, which can lead to unintended mutations and genetic instability. Off-target effects occur when the gene-editing tool, such as CRISPR/Cas9, introduces changes at unintended genomic sites. These off-target mutations can have deleterious effects, including the activation of oncogenes or the disruption of essential regulatory genes. A study on cytosine base editors revealed that these tools could induce numerous off-target single-nucleotide variants, highlighting the need for more precise gene-editing techniques (Zuo et al., 2019). Ensuring the long-term genetic stability of modified organs is another critical challenge. Genetic modifications must remain stable across multiple generations of cells and throughout the lifespan of the transplanted organ. Instability in the inserted genes can lead to loss of function or the re-emergence of immunogenic epitopes, which can compromise graft survival. Techniques like DISCOVER-Seq are being developed to monitor and detect off-target effects in vivo, providing a more comprehensive understanding of the genomic stability of edited cells (Wienert et al., 2018). Moreover, the genetic environment of the host can influence the stability and expression of the modified genes. Interactions between the host genome and the introduced genes can lead to unpredictable outcomes, necessitating thorough preclinical testing and long-term monitoring to ensure the safety and efficacy of the genetically modified organs (Jin et al., 2019). 8.3 Long-term monitoring and management of graft function Long-term monitoring and management of graft function are crucial for the success of xenotransplantation. Continuous assessment is necessary to detect early signs of rejection, infection, or other complications that could compromise the graft. Advances in biomarkers and non-invasive monitoring techniques are essential for real-time evaluation of graft health. For instance, a three-gene assay has been developed to monitor immune quiescence and predict graft stability in kidney transplant patients, highlighting the potential of gene expression profiling in graft monitoring (Roedder et al., 2015). The management of immunosuppression is another critical aspect. Balancing the need to prevent rejection while minimizing the side effects of long-term immunosuppressive therapy is challenging. Over-immunosuppression
RkJQdWJsaXNoZXIy MjQ4ODYzNQ==